Beiersdorf has launched a new anti-aging approach inspired by epigenetics, making its advances accessible with Nivea and Ultimate Youth Epigenetic Serum. This innovation targets in-depth skin rejuvenation.
With a history marked by innovation in skin care, Beiersdorf continues to redefine the anti-aging market. Their latest research has led to the creation of Ultimate Youth Epigenetic Serum, a product promising to slow and then reverse skin aging thanks to Epicellin, a compound developed after 15 years of research.
The results, based on the use of Beiersdorf's proprietary "age clock" technology, are designed to show noticeable changes in just two weeks of application, positioning the product as a potential market leader.
" With over a century of expertise, Nivea continues to lead the way in advanced skin science. Our research has enabled us to redefine what is possible in skin rejuvenation, and above all, to continue to empower people to feel good about themselves. "says Leonie Rödig, Vice President, Nivea Face Care.
The serum is enriched not only with Epicelline, but also with three forms of hyaluronic acid, making the formulation highly effective in terms of skin rejuvenation. The company plans to launch this product on the European market by the end of 2025, before extending distribution to a further 30 countries.
Dr. Gitta Neufang, Director of Research and Development at Beiersdorf, explains that epigenetics allows us to study how lifestyle and environment - referred to as "epigenetic factors" - influence skin gene expression without altering the DNA sequence. "" More than 15 years of scientific research have enabled us to isolate our own 'Skin Age Clock' technology and exploit its full potential, paving the way for a new generation of high-end anti-aging skincare products. "
